港股异动丨药明生物低开3.4%，遭主要股东减持

Core Viewpoint - WuXi Biologics (2269.HK) experienced a 3.4% decline, closing at HKD 38.66, following the announcement of a block trade agreement involving its major shareholder, Biologics Holdings [1] Group 1 - Biologics Holdings has entered into a block trade agreement with Morgan Stanley to sell 150 million shares of WuXi Biologics [1] - The shares being sold represent approximately 3.63% of the total issued share capital of the company [1] - The sale price is set at HKD 38.52 per share, which reflects a discount of 3.75% compared to the closing price of HKD 40.02 on the previous day [1] Group 2 - The total amount involved in the transaction is approximately HKD 5.778 billion [1]